Background: Stroke rehabilitation trials involve heterogenous samples with varying interventions, rendering the results difficult to generalise to the stroke population. Patients with communication and cognitive barriers are often excluded due to perceived participation difficulties in exercise therapies. The challenge of maintaining a balance between equitable representation and targeted research is an ongoing conundrum in trial designs. Strict eligibility criteria can limit generalisability, delay recruitment, and increase health inequities.
Aim: To review the literature and identify key eligibility criteria used in stroke exercise trials that limit recruitment.
Methods: A systematic review of stroke rehabilitation RCTs published 2017-2022 were included from an electronic database search (PUBMED). The inclusion criteria were: 1) randomised controlled trials, 2) ischaemic or haemorrhagic stroke patients, 3) exercise intervention, 4) cognitive outcomes (either primary or secondary) and 5) publication within the last 5 years (to capture pre- and peri-pandemic studies). Included and excluded studies were reported as per PRISMA guidelines.
Results: Eighty studies were identified with 19 (n=1908) included in the final review. A significant number of trials excluded aphasia (37%), had cognitive restrictions (68%) or mobility limits (58%). The presence of co-morbid conditions such as neurological or psychiatric conditions were also common exclusion criterion (63%). The recruitment rate varied from 2% to 100%, with a mean of 48%. The most common exclusion reason was “does not meet eligibility criteria” (n=4604, 62%) followed by “declined to participate” (n=2242, 30%). Interestingly, 476 (6%) patients were excluded due to convenience reasons (e.g., lived too far away).
Conclusion: Despite being frequent post-stroke deficits, aphasia and cognitive impairment were common exclusions in stroke recovery exercise trials, limiting the applicability of such therapies in stroke survivors and significantly reducing accessible cohorts. Researchers must expand the inclusivity of their trials to ensure all stroke patients who are presumed to benefit from an intervention are represented.